• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰高血糖素受体中的变构通讯机制。

Allosteric communication mechanism in the glucagon receptor.

作者信息

van der Velden Wijnand J C, Mukhaleva Elizaveta, Vaidehi Nagarajan

机构信息

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, California, USA.

Department of Computational and Quantitative Medicine, Beckman Research Institute of the City of Hope, Duarte, California, USA.

出版信息

J Biol Chem. 2025 Apr 23;301(6):108530. doi: 10.1016/j.jbc.2025.108530.

DOI:10.1016/j.jbc.2025.108530
PMID:40280422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12145835/
Abstract

Recent drug development suggests agonists may be more promising against glucagon receptor dysregulation in metabolic disorders. Allosteric modulation may pave an alternative way to initiate responses that are required to target these metabolic disorders. Here, we investigated the allosteric communication mechanisms within the glucagon receptor using molecular dynamics simulations on five receptor states. Results highlighted that the extracellular domain is dynamic in the absence of an orthosteric agonist. In the presence of a partial agonist, we observed increased flexibility in the N terminus of the receptor compared with the full agonist-bound receptor. Class B1 G protein-coupled receptor (GPCR) microswitches showed repacking going from the inactive state to the active state, allowing for G protein coupling. In the full agonist- and G protein-bound state, Gα showed both translational and rotational movement in the N terminus, core, and α5-helix, thereby forming key interactions between the core of the G protein and the receptor. Finally, the allosteric communication from the extracellular region to the G protein coupling region of the receptor was the strongest in the intracellular negative allosteric modulator-bound state, the full agonist and G protein-bound state, and the full agonist-bound G protein-free state. The residue positions predicted to play a significant role in the allosteric communication mechanism showed overlap with disease-associated mutations. Overall, our study provides insights into the allosteric communication mechanism in a class B1 GPCR, which sets the foundation for future design of allosteric modulators targeting the glucagon receptor.

摘要

近期的药物研发表明,激动剂在对抗代谢紊乱中的胰高血糖素受体失调方面可能更具前景。变构调节可能为引发针对这些代谢紊乱所需的反应开辟一条替代途径。在此,我们通过对五种受体状态进行分子动力学模拟,研究了胰高血糖素受体内的变构通讯机制。结果表明,在没有正构激动剂的情况下,细胞外结构域是动态的。在存在部分激动剂的情况下,我们观察到与完全激动剂结合的受体相比,该受体的N端灵活性增加。B1类G蛋白偶联受体(GPCR)微开关显示从非活性状态到活性状态的重新排列,从而实现G蛋白偶联。在完全激动剂和G蛋白结合状态下,Gα在N端、核心和α5螺旋中均表现出平移和旋转运动,从而在G蛋白核心与受体之间形成关键相互作用。最后,从细胞外区域到受体的G蛋白偶联区域的变构通讯在细胞内负变构调节剂结合状态、完全激动剂和G蛋白结合状态以及完全激动剂结合的无G蛋白状态下最强。预测在变构通讯机制中起重要作用的残基位置与疾病相关突变存在重叠。总体而言,我们的研究为B1类GPCR中的变构通讯机制提供了见解,为未来设计靶向胰高血糖素受体的变构调节剂奠定了基础。

相似文献

1
Allosteric communication mechanism in the glucagon receptor.胰高血糖素受体中的变构通讯机制。
J Biol Chem. 2025 Apr 23;301(6):108530. doi: 10.1016/j.jbc.2025.108530.
2
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
3
Brexanolone, zuranolone and related neurosteroid GABA receptor positive allosteric modulators for postnatal depression.用于产后抑郁症的布雷沙诺龙、祖拉诺龙及相关神经甾体GABA受体正变构调节剂。
Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2.
4
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
5
Designing Structure-specific and Switchable Allosteric Effectors for GPCRs Based on the Causality and Energetics of Inherent Signaling.基于固有信号的因果关系和能量学设计针对G蛋白偶联受体的结构特异性和可切换变构效应剂。
J Mol Biol. 2025 Jun 11:169293. doi: 10.1016/j.jmb.2025.169293.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
8
Computational model predicts function of Rho-GTPase binding for plexin receptor GAP activity on Rap1b via dynamic allosteric changes.计算模型通过动态变构变化预测丛状蛋白受体对Rap1b的Rho-GTPase结合的GAP活性功能。
Protein Sci. 2025 Jul;34(7):e70196. doi: 10.1002/pro.70196.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models.解析 B1 类 G 蛋白偶联受体细胞外结构域构象变化与甲状旁腺激素 1 型受体激活的相互作用:增强采样分子动力学模拟与马尔可夫状态模型的整合。
ACS Chem Neurosci. 2024 Feb 21;15(4):844-853. doi: 10.1021/acschemneuro.3c00747. Epub 2024 Feb 5.
2
Single-molecule analysis reveals that a glucagon-bound extracellular domain of the glucagon receptor is dynamic.单分子分析揭示,与胰高血糖素结合的胰高血糖素受体的细胞外结构域是动态的。
J Biol Chem. 2023 Sep;299(9):105160. doi: 10.1016/j.jbc.2023.105160. Epub 2023 Aug 14.
3
Unraveling allostery within the angiotensin II type 1 receptor for Gα and β-arrestin coupling.解析血管紧张素 II 型 1 受体与 Gα 和 β-arrestin 偶联的变构机制。
Sci Signal. 2023 Aug 8;16(797):eadf2173. doi: 10.1126/scisignal.adf2173.
4
Conserved class B GPCR activation by a biased intracellular agonist.保守的 B 类 GPCR 通过偏向性细胞内激动剂激活。
Nature. 2023 Sep;621(7979):635-641. doi: 10.1038/s41586-023-06467-w. Epub 2023 Jul 31.
5
100 years of glucagon and 100 more.百年胰高血糖素,未来更多彩。
Diabetologia. 2023 Aug;66(8):1378-1394. doi: 10.1007/s00125-023-05947-y. Epub 2023 Jun 27.
6
Class B1 GPCR activation by an intracellular agonist.B1 类 G 蛋白偶联受体的细胞内激动剂激活。
Nature. 2023 Jun;618(7967):1085-1093. doi: 10.1038/s41586-023-06169-3. Epub 2023 Jun 7.
7
Molecular insights into peptide agonist engagement with the PTH receptor.解析肽激动剂与甲状旁腺激素受体结合的分子机制。
Structure. 2023 Jun 1;31(6):668-676.e5. doi: 10.1016/j.str.2023.04.002. Epub 2023 May 5.
8
Function and dynamics of the intrinsically disordered carboxyl terminus of β2 adrenergic receptor.β2 肾上腺素能受体无规则羧基末端的功能和动力学。
Nat Commun. 2023 Apr 10;14(1):2005. doi: 10.1038/s41467-023-37233-1.
9
Negative allosteric modulation of the glucagon receptor by RAMP2.RAMP2 对胰高血糖素受体的负变构调节。
Cell. 2023 Mar 30;186(7):1465-1477.e18. doi: 10.1016/j.cell.2023.02.028.
10
The molecular pharmacology of glucagon agonists in diabetes and obesity.胰高血糖素激动剂在糖尿病和肥胖症中的分子药理学。
Peptides. 2023 Jul;165:171003. doi: 10.1016/j.peptides.2023.171003. Epub 2023 Mar 29.